Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 836485, 32 pages
http://dx.doi.org/10.1155/2012/836485
Review Article

The Effects of TLR Activation on T-Cell Development and Differentiation

1Department of Gastroenterology, The 309th Hospital of The People's Liberation Army, Beijing 100091, China
2Department of Infectious Diseases, Naval General Hospital, Beijing 100048, China
3Savient Pharmaceuticals, East Brunswick, NJ 08116, USA

Received 14 November 2011; Accepted 26 January 2012

Academic Editor: Ana Lepique

Copyright © 2012 Bo Jin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. A. Janeway Jr., “Approaching the asymptote? Evolution and revolution in immunology,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 54, no. 1, pp. 1–13, 1989. View at Google Scholar · View at Scopus
  2. C. A. Janeway Jr., “The immune system evolved to discriminate infectious nonself from noninfectious self,” Immunology Today, vol. 13, no. 1, pp. 11–16, 1992. View at Google Scholar · View at Scopus
  3. R. Medzhitov and C. A. Janeway Jr., “Decoding the patterns of self and nonself by the innate immune system,” Science, vol. 296, no. 5566, pp. 298–300, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Kumar, T. Kawai, and S. Akira, “Pathogen recognition by the innate immune system,” International Reviews of Immunology, vol. 30, no. 1, pp. 16–34, 2011. View at Publisher · View at Google Scholar
  5. G. Hajishengallis and J. D. Lambris, “Microbial manipulation of receptor crosstalk in innate immunity,” Nature Reviews Immunology, vol. 11, no. 3, pp. 187–200, 2011. View at Publisher · View at Google Scholar
  6. F. Osorio and C. Reis e Sousa, “Myeloid C-type lectin receptors in pathogen recognition and host defense,” Immunity, vol. 34, no. 5, pp. 651–664, 2011. View at Publisher · View at Google Scholar
  7. H. Kumar, T. Kawai, and S. Akira, “Toll-like receptors and innate immunity,” Biochemical and Biophysical Research Communications, vol. 388, no. 4, pp. 621–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Ranjan, J. B. Bowzard, J. W. Schwerzmann, V. Jeisy-Scott, T. Fujita, and S. Sambhara, “Cytoplasmic nucleic acid sensors in antiviral immunity,” Trends in Molecular Medicine, vol. 15, no. 8, pp. 359–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Yanai, D. Savitsky, T. Tamura, and T. Taniguchi, “Regulation of the cytosolic DNA-sensing system in innate immunity: a current view,” Current Opinion in Immunology, vol. 21, no. 1, pp. 17–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Wang, M. K. Choi, T. Ban et al., “Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 14, pp. 5477–5482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Sharma and K. A. Fitzgerald, “Innate immune sensing of DNA,” PLoS Pathogens, vol. 7, no. 4, Article ID e1001310, 2011. View at Publisher · View at Google Scholar
  12. R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway, “A human homologue of the Drosophila toll protein signals activation of adaptive immunity,” Nature, vol. 388, no. 6640, pp. 394–397, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. L. C. Parker, L. R. Prince, and I. Sabroe, “Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity,” Clinical and Experimental Immunology, vol. 147, no. 2, pp. 199–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Pasare and R. Medzhitov, “Control of B-cell responses by Toll-like receptors,” Nature, vol. 438, no. 7066, pp. 364–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. N. W. Palm and R. Medzhitov, “Pattern recognition receptors and control of adaptive immunity,” Immunological Reviews, vol. 227, no. 1, pp. 221–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Tuettenberg, C. Becker, A. Correll, K. Steinbrink, and H. Jonuleit, “Immune regulation by dendritic cells and T cells—basic science, diagnostic, and clinical application,” Clinical Laboratory, vol. 57, no. 1-2, pp. 1–12, 2011. View at Google Scholar
  17. V. Appay, R. A. W. Van Lier, F. Sallusto, and M. Roederer, “Phenotype and function of human T lymphocyte subsets: consensus and issues,” Cytometry Part A, vol. 73, no. 11, pp. 975–983, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. B. J. Fowlkes, L. Edison, B. J. Mathieson, and T. M. Chused, “Early T lymphocytes. Differentiation in vivo of adult intrathymic precursor cells,” Journal of Experimental Medicine, vol. 162, no. 3, pp. 802–822, 1985. View at Google Scholar · View at Scopus
  19. N. M. Le Douarin and F. V. Jotereau, “Tracing of cells of the avian thymus through embryonic life in interspecific chimeras,” Journal of Experimental Medicine, vol. 142, no. 1, pp. 17–40, 1975. View at Google Scholar · View at Scopus
  20. P. E. Love and A. Bhandoola, “Signal integration and crosstalk during thymocyte migration and emigration,” Nature Reviews Immunology, vol. 11, no. 7, pp. 469–477, 2011. View at Publisher · View at Google Scholar
  21. J. Li, N. Iwanami, Q. H. Vu, M. Furutani-Seiki, and Y. Takahama, “Noninvasive intravital imaging of thymocyte dynamics in Medaka,” Journal of Immunology, vol. 179, no. 3, pp. 1605–1615, 2007. View at Google Scholar · View at Scopus
  22. F. M. V. Rossi, S. Y. Corbel, J. S. Merzaban et al., “Recruitment of adult thymic progenitors is regulated by P-selectin and its ligand PSGL-1,” Nature Immunology, vol. 6, no. 6, pp. 626–634, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Liu, F. Saito, Z. Liu et al., “Coordination between CCR7- and CCR9-mediated chemokine signals in prevascular fetal thymus colonization,” Blood, vol. 108, no. 8, pp. 2531–2539, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Scollay, P. Bartlett, and K. Shortman, “T cell development in the adult murine thymus: changes in the expression of the surface antigens Ly2, L3T4 and B2A2 during development from early precursor cells to emigrants,” Immunological Reviews, vol. 82, pp. 79–103, 1984. View at Google Scholar · View at Scopus
  25. S. Habu, M. Kimura, M. Katsuki, K. Hioki, and T. Nomura, “Correlation of T cell receptor gene rearrangements to T cell surface antigen expression and to serum immunoglobulin level in scid mice,” European Journal of Immunology, vol. 17, no. 10, pp. 1467–1471, 1987. View at Google Scholar · View at Scopus
  26. E. F. Lind, S. E. Prockop, H. E. Porritt, and H. T. Petrie, “Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development,” Journal of Experimental Medicine, vol. 194, no. 2, pp. 127–134, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. J. C. Zúñiga-Pflücker, “The original intrathymic progenitor from which T cells originate,” Journal of Immunology, vol. 183, no. 1, pp. 3–4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Takahama, E. W. Shores, and A. Singer, “Negative selection of precursor thymocytes before their differentiation into CD4+CD8+ cells,” Science, vol. 258, no. 5082, pp. 653–656, 1992. View at Google Scholar · View at Scopus
  29. R. L. Kortum, C. L. Sommers, C. P. Alexander et al., “Targeted Sos1 deletion reveals its critical role in early T-cell development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 30, pp. 12407–12412, 2011. View at Publisher · View at Google Scholar
  30. T. Nitta, S. Murata, T. Ueno, K. Tanaka, and Y. Takahama, “Thymic microenvironments for T-cell repertoire formation,” Advances in Immunology, vol. 99, pp. 59–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Murata, Y. Takahama, and K. Tanaka, “Thymoproteasome: probable role in generating positively selecting peptides,” Current Opinion in Immunology, vol. 20, no. 2, pp. 192–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Weinreich and K. A. Hogquist, “Thymic emigration: when and how T cells leave home,” Journal of Immunology, vol. 181, no. 4, pp. 2265–2270, 2008. View at Google Scholar · View at Scopus
  33. J. Derbinski, A. Schulte, B. Kyewski, and L. Klein, “Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self,” Nature Immunology, vol. 2, no. 11, pp. 1032–1039, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. M. S. Anderson, E. S. Venanzi, L. Klein et al., “Projection of an immunological self shadow within the thymus by the aire protein,” Science, vol. 298, no. 5597, pp. 1395–1401, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Bonasio, M. L. Scimone, P. Schaerli, N. Grabie, A. H. Lichtman, and U. H. von Andrian, “Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus,” Nature Immunology, vol. 7, no. 10, pp. 1092–1100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Mori, M. Itoi, N. Tsukamoto, H. Kubo, and T. Amagai, “The perivascular space as a path of hematopoietic progenitor cells and mature T cells between the blood circulation and the thymic parenchyma,” International Immunology, vol. 19, no. 6, pp. 745–753, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Matloubian, C. G. Lo, G. Cinamon et al., “Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1,” Nature, vol. 427, no. 6972, pp. 355–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. M. L. Allende, J. L. Dreier, S. Mandala, and R. L. Proia, “Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration,” Journal of Biological Chemistry, vol. 279, no. 15, pp. 15396–15401, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. P. J. Fink and D. W. Hendricks, “Post-thymic maturation: young T cells assert their individuality,” Nature Reviews Immunology, vol. 11, no. 8, pp. 544–549, 2011. View at Publisher · View at Google Scholar
  40. C. W. J. Lio and C. S. Hsieh, “Becoming self-aware: the thymic education of regulatory T cells,” Current Opinion in Immunology, vol. 23, no. 2, pp. 213–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. H. R. Rodewald, S. Paul, C. Haller, H. Bluethmann, and C. Blum, “Thymus medulla consisting of epithelial islets each derived from a single progenitor,” Nature, vol. 414, no. 6865, pp. 763–768, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. D. L. Mueller, “Mechanisms maintaining peripheral tolerance,” Nature Immunology, vol. 11, no. 1, pp. 21–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Zal, A. Volkmann, and B. Stockinger, “Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen,” Journal of Experimental Medicine, vol. 180, no. 6, pp. 2089–2099, 1994. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Hinterberger, M. Aichinger, O. P. Da Costa, D. Voehringer, R. Hoffmann, and L. Klein, “Autonomous role of medullary thymic epithelial cells in central CD4+ T cell tolerance,” Nature Immunology, vol. 11, no. 6, pp. 512–519, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Román, H. Shino, F. X. F. Qin, and Y. J. Liu, “Cutting edge: hematopoietic-derived APCs select regulatory T cells in thymus,” Journal of Immunology, vol. 185, no. 7, pp. 3819–3823, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. I. Proietto, S. Van Dommelen, P. Zhou et al., “Dendritic cells in the thymus contribute to T-regulatory cell induction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19869–19874, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. A. M. Gallegos and M. J. Bevan, “Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation,” Journal of Experimental Medicine, vol. 200, no. 8, pp. 1039–1049, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Nunes-Cabaço, I. Caramalho, N. Sepúlveda, and A. E. Sousa, “Differentiation of human thymic regulatory T cells at the double positive stage,” European Journal of Immunology, vol. 41, no. 12, pp. 3604–3614, 2011. View at Publisher · View at Google Scholar
  49. N. Watanabe, S. Hanabuchi, V. Soumelis et al., “Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion,” Nature Immunology, vol. 5, no. 4, pp. 426–434, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Y. Liu, P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, and D. C. Wraith, “Low avidity recognition of self-antigen by T cells permits escape from central tolerance,” Immunity, vol. 3, no. 4, pp. 407–415, 1995. View at Google Scholar · View at Scopus
  51. A. L. Fletcher, D. Malhotra, and S. J. Turley, “Lymph node stroma broaden the peripheral tolerance paradigm,” Trends in Immunology, vol. 32, no. 1, pp. 12–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. T. C. Metzger and M. S. Anderson, “Control of central and peripheral tolerance by Aire,” Immunological Reviews, vol. 241, no. 1, pp. 89–103, 2011. View at Publisher · View at Google Scholar
  53. J. M. Gardner, J. J. DeVoss, R. S. Friedman et al., “Deletional tolerance mediated by extrathymic aire-expressing cells,” Science, vol. 321, no. 5890, pp. 843–847, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. J. N. Cohen, C. J. Guidi, E. F. Tewalt et al., “Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation,” Journal of Experimental Medicine, vol. 207, no. 4, pp. 681–688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Yip, L. Su, D. Sheng et al., “Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes,” Nature Immunology, vol. 10, no. 9, pp. 1026–1033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. A. L. Fletcher, V. Lukacs-Kornek, E. D. Reynoso et al., “Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions,” Journal of Experimental Medicine, vol. 207, no. 4, pp. 689–697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. J. W. Lee, M. Epardaud, J. Sun et al., “Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self,” Nature Immunology, vol. 8, no. 2, pp. 181–190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Tokuda, T. Adachi, Y. Adachi et al., “Identification of FABP7 in fibroblastic reticular cells of mouse lymph nodes,” Histochemistry and Cell Biology, vol. 134, no. 5, pp. 445–452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. C. C. Clement, O. Rotzschke, and L. Santambrogio, “The lymph as a pool of self-antigens,” Trends in Immunology, vol. 32, no. 1, pp. 6–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. C. C. Clement, E. S. Cannizzo, M. D. Nastke et al., “An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma,” PloS One, vol. 5, no. 3, Article ID e9863, 2010. View at Google Scholar
  61. P. Marrack and J. Kappler, “Control of T cell viability,” Annual Review of Immunology, vol. 22, pp. 765–787, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. V. Benseler, A. Warren, M. Vo et al., “Hepatocyte entry leads to degradation of autoreactive CD8 T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 40, pp. 16735–16740, 2011. View at Publisher · View at Google Scholar
  63. J. G. Humble, W. H. Jayne, and R. J. Pulvertaft, “Biological interaction between lymphocytes and other cells,” British journal of haematology, vol. 2, no. 3, pp. 283–294, 1956. View at Google Scholar · View at Scopus
  64. W. H. Lewis, “The engulfment of living blood cells by others of the same type,” The Anatomical Record, vol. 31, no. 1, pp. 43–49, 1925. View at Google Scholar
  65. H. Bour-Jordan, J. H. Esensten, M. Martinez-Llordella, C. Penaranda, M. Stumpf, and J. A. Bluestone, “Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family,” Immunological Reviews, vol. 241, no. 1, pp. 180–205, 2011. View at Publisher · View at Google Scholar
  66. B. S. Reis and D. Mucida, “The role of the intestinal context in the generation of tolerance and inflammation,” Clinical and Developmental Immunology, vol. 2012, Article ID 157948, 6 pages, 2012. View at Publisher · View at Google Scholar
  67. H. L. Weiner, A. P. da Cunha, F. Quintana, and H. Wu, “Oral tolerance,” Immunological Reviews, vol. 241, no. 1, pp. 241–259, 2011. View at Publisher · View at Google Scholar
  68. G. B. Olson and B. S. Wostmann, “Lymphocytopoiesis, plasmacytopoiesis and cellular proliferation in nonantigenically stimulated germfree mice,” Journal of Immunology, vol. 97, no. 2, pp. 267–274, 1966. View at Google Scholar · View at Scopus
  69. W. S. Garrett, J. I. Gordon, and L. H. Glimcher, “Homeostasis and Inflammation in the Intestine,” Cell, vol. 140, no. 6, pp. 859–870, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. N. A. Bos, C. G. Meeuwsen, B. S. Wostmann, J. R. Pleasants, and R. Benner, “The influence of exogenous antigenic stimulation on the specificity repertoire of background immunoglobulin-secreting cells of different isotypes,” Cellular Immunology, vol. 112, no. 2, pp. 371–380, 1988. View at Google Scholar · View at Scopus
  71. K. M. Maslowski, A. T. Vieira, A. Ng et al., “Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43,” Nature, vol. 461, no. 7268, pp. 1282–1286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. J. da Silva Menezes, D. de Sousa Mucida, D. C. Cara et al., “Stimulation by food proteins plays a critical role in the maturation of the immune system,” International Immunology, vol. 15, no. 3, pp. 447–455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. J. F. Amaral, A. C. Gomes-Santos, J. Paula-Silva et al., “Antigenic dietary protein guides maturation of the host immune system promoting resistance to Leishmania major infection in C57BL/6 mice,” Immunology, vol. 129, no. 3, pp. 455–464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. D. G. Hanson, N. M. Vaz, L. C. Maia, M. M. Hornbrook, J. M. Lynch, and C. A. Roy, “Inhibition of specific immune responses by feeding protein antigens,” International Archives of Allergy and Applied Immunology, vol. 55, no. 1–6, pp. 526–532, 1977. View at Google Scholar · View at Scopus
  75. L. K. Richman, J. M. Chiller, and W. R. Brown, “Enterically induced immunologic tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins,” Journal of Immunology, vol. 121, no. 6, pp. 2429–2434, 1978. View at Google Scholar
  76. D. Mucida, N. Kutchukhidze, A. Erazo, M. Russo, J. J. Lafaille, and M. A. Curotto De Lafaille, “Oral tolerance in the absence of naturally occurring Tregs,” Journal of Clinical Investigation, vol. 115, no. 7, pp. 1923–1933, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Mayer and L. Shao, “Therapeutic potential of oral tolerance,” Nature Reviews Immunology, vol. 4, no. 6, pp. 407–419, 2004. View at Google Scholar · View at Scopus
  78. M. Iwata, A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato, and S. Y. Song, “Retinoic acid imprints gut-homing specificity on T cells,” Immunity, vol. 21, no. 4, pp. 527–538, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. J. R. Mora, M. Iwata, B. Eksteen et al., “Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells,” Science, vol. 314, no. 5802, pp. 1157–1160, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. J. A. Bluestone, “Mechanisms of tolerance,” Immunological Reviews, vol. 241, no. 1, pp. 5–19, 2011. View at Publisher · View at Google Scholar
  81. J. L. Coombes, K. R. R. Siddiqui, C. V. Arancibia-Cárcamo et al., “A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β -and retinoic acid-dependent mechanism,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1757–1764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. E. Jaensson, H. Uronen-Hansson, O. Pabst et al., “Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans,” Journal of Experimental Medicine, vol. 205, no. 9, pp. 2139–2149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. J. M. Kyd and A. W. Cripps, “Functional differences between M cells and enterocytes in sampling luminal antigens,” Vaccine, vol. 26, no. 49, pp. 6221–6224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Yoshida, K. Kobayashi, T. T. Kuo et al., “Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria,” Journal of Clinical Investigation, vol. 116, no. 8, pp. 2142–2151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Rescigno, “Intestinal dendritic cells,” Advances in Immunology, vol. 107, pp. 109–138, 2010. View at Publisher · View at Google Scholar
  86. M. Chieppa, M. Rescigno, A. Y. C. Huang, and R. N. Germain, “Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement,” Journal of Experimental Medicine, vol. 203, no. 13, pp. 2841–2852, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. D. Mucida, Y. Park, G. Kim et al., “Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid,” Science, vol. 317, no. 5835, pp. 256–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. G. Matteoli, E. Mazzini, I. D. Iliev et al., “Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction,” Gut, vol. 59, no. 5, pp. 595–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. M. T. Pallotta, C. Orabona, C. Volpi et al., “Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells,” Nature Immunology, vol. 12, no. 9, pp. 870–878, 2011. View at Publisher · View at Google Scholar
  90. D. M. Miller, Y. Ogawa, K. K. Iwata et al., “Characterization of the binding of transforming growth factor-β1, -β2, and -β3 to recombinant β1-latency-associated peptide,” Molecular Endocrinology, vol. 6, no. 5, pp. 694–702, 1992. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Awasthi, Y. Carrier, J. P. S. Peron et al., “A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells,” Nature Immunology, vol. 8, no. 12, pp. 1380–1389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. M. A. Curotto de Lafaille, N. Kutchukhidze, S. Shen, Y. Ding, H. Yee, and J. J. Lafaille, “Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation,” Immunity, vol. 29, no. 1, pp. 114–126, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Ochi, M. Abraham, H. Ishikawa et al., “Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25-LAP+ T cells,” Nature Medicine, vol. 12, no. 6, pp. 627–635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. F. J. Quintana, G. Murugaiyan, M. F. Farez et al., “An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 48, pp. 20768–20773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. L. Apetoh, F. J. Quintana, C. Pot et al., “The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27,” Nature Immunology, vol. 11, no. 9, pp. 854–861, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. H. L. Weiner, “The mucosal milieu creates tolerogenic dendritic cells and TR l and TH3 regulatory cells,” Nature Immunology, vol. 2, no. 8, pp. 671–672, 2001. View at Publisher · View at Google Scholar · View at Scopus
  97. H. Y. Wu, F. J. Quintana, and H. L. Weiner, “Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+CD25-LAP+ regulatory T Cell and is associated with down-regulation of IL-17+CD4+ICOS+CXCR5+ follicular helper T cells,” Journal of Immunology, vol. 181, no. 9, pp. 6038–6050, 2008. View at Google Scholar · View at Scopus
  98. A. M. C. Faria and H. L. Weiner, “Oral tolerance: therapeutic implications for autoimmune diseases,” Clinical and Developmental Immunology, vol. 13, no. 2–4, pp. 143–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. O. Akbari, R. H. DeKruyff, and D. T. Umetsu, “Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen,” Nature Immunology, vol. 2, no. 8, pp. 725–731, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Ostroukhova, C. Seguin-Devaux, T. B. Oriss et al., “Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FOXP3,” Journal of Clinical Investigation, vol. 114, no. 1, pp. 28–38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. G. Hintzen, L. Ohl, M.-L. Del Rio et al., “Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node,” Journal of Immunology, vol. 177, no. 10, pp. 7346–7354, 2006. View at Google Scholar
  102. H. Nakano, M. E. Free, G. S. Whitehead et al., “Pulmonary CD103+ dendritic cells prime Th2 responses to inhaled allergens,” Mucosal Immunology, vol. 5, no. 1, pp. 53–65, 2012. View at Publisher · View at Google Scholar
  103. J. Zhu, H. Yamane, and W. E. Paul, “Differentiation of effector CD4+ T cell populations,” Annual Review of Immunology, vol. 28, pp. 445–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. R. I. Nurieva, Y. Chung, D. Hwang et al., “Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages,” Immunity, vol. 29, no. 1, pp. 138–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. C. King, S. G. Tangye, and C. R. Mackay, “T follicular helper (TFH) cells in normal and dysregulated immune responses,” Annual Review of Immunology, vol. 26, pp. 741–766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Vogelzang, H. M. McGuire, D. Yu, J. Sprent, C. R. Mackay, and C. King, “A fundamental role for interleukin-21 in the generation of T follicular helper cells,” Immunity, vol. 29, no. 1, pp. 127–137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Veldhoen, C. Uyttenhove, J. van Snick et al., “Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset,” Nature Immunology, vol. 9, no. 12, pp. 1341–1346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. V. Dardalhon, A. Awasthi, H. Kwon et al., “IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3- effector T cells,” Nature Immunology, vol. 9, no. 12, pp. 1347–1355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Eyerich, K. Eyerich, D. Pennino et al., “Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling,” Journal of Clinical Investigation, vol. 119, no. 12, pp. 3573–3585, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. R. M. Locksley, “Nine lives: plasticity among T helper cell subsets,” Journal of Experimental Medicine, vol. 206, no. 8, pp. 1643–1646, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. C. S. Hsieh, S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy, “Development of T(H)1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages,” Science, vol. 260, no. 5107, pp. 547–549, 1993. View at Google Scholar · View at Scopus
  112. A. A. Lighvani, D. M. Frucht, D. Jankovic et al., “T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 15137–15142, 2001. View at Publisher · View at Google Scholar · View at Scopus
  113. G. Le Gros, S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul, “Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells,” Journal of Experimental Medicine, vol. 172, no. 3, pp. 921–929, 1990. View at Publisher · View at Google Scholar · View at Scopus
  114. S. L. Swain, A. D. Weinberg, M. English, and G. Huston, “IL-4 directs the development of Th2-like helper effectors,” Journal of Immunology, vol. 145, no. 11, pp. 3796–3806, 1990. View at Google Scholar · View at Scopus
  115. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. R. A. Flavell, S. Sanjabi, S. H. Wrzesinski, and P. Licona-Limón, “The polarization of immune cells in the tumour environment by TGFβ,” Nature Reviews Immunology, vol. 10, no. 8, pp. 554–567, 2010. View at Publisher · View at Google Scholar
  117. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  118. T. Korn, E. Bettelli, W. Gao et al., “IL-21 initiates an alternative pathway to induce proinflammatory T H17 cells,” Nature, vol. 448, no. 7152, pp. 484–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. N. Schmitt, R. Morita, L. Bourdery et al., “Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12,” Immunity, vol. 31, no. 1, pp. 158–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. O. Dienz, S. M. Eaton, J. P. Bond et al., “The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells,” Journal of Experimental Medicine, vol. 206, no. 1, pp. 69–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. D. Yu and C. G. Vinuesa, “The elusive identity of T follicular helper cells,” Trends in Immunology, vol. 31, no. 10, pp. 377–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. M. A. Linterman and C. G. Vinuesa, “Signals that influence T follicular helper cell differentiation and function,” Seminars in Immunopathology, vol. 32, no. 2, pp. 183–196, 2010. View at Publisher · View at Google Scholar
  123. S. J. Szabo, S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher, “A novel transcription factor, T-bet, directs Th1 lineage commitment,” Cell, vol. 100, no. 6, pp. 655–669, 2000. View at Google Scholar · View at Scopus
  124. A. C. Mullen, F. A. High, A. S. Hutchins et al., “Role of T-bet in commitment of TH1 cells before IL- 12-dependent selection,” Science, vol. 292, no. 5523, pp. 1907–1910, 2001. View at Publisher · View at Google Scholar · View at Scopus
  125. A. C. Mullen, A. S. Hutchins, F. A. High et al., “Hlx is induced by and genetically interacts with T-bet to promote heritable THI gene induction,” Nature Immunology, vol. 3, no. 7, pp. 652–658, 2002. View at Publisher · View at Google Scholar · View at Scopus
  126. B. D. Korman, D. L. Kastner, P. K. Gregersen, and E. F. Remmers, “STAT4: genetics, mechanisms, and implications for autoimmunity,” Current allergy and asthma reports, vol. 8, no. 5, pp. 398–403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. A. Balasubramani, Y. Shibata, G. E. Crawford, A. S. Baldwin, R. D. Hatton, and C. T. Weaver, “Modular utilization of distal cis-regulatory elements controls Ifng gene expression in T cells activated by distinct stimuli,” Immunity, vol. 33, no. 1, pp. 35–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  128. M. Afkarian, J. R. Sedy, J. Yang et al., “T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells,” Nature Immunology, vol. 3, no. 6, pp. 549–557, 2002. View at Google Scholar
  129. W. P. Zheng and R. A. Flavell, “The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells,” Cell, vol. 89, no. 4, pp. 587–596, 1997. View at Google Scholar · View at Scopus
  130. J. Zhu, B. Min, J. Hu-Li et al., “Conditional deletion of Gata3 shows its essential function in TH1-TH2 responses,” Nature Immunology, vol. 5, no. 11, pp. 1157–1165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  131. S. Y. Pai, M. L. Truitt, and I. C. Ho, “GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 7, pp. 1993–1998, 2004. View at Publisher · View at Google Scholar · View at Scopus
  132. S. Horiuchi, A. Onodera, H. Hosokawa et al., “Genome-wide analysis reveals unique regulation of transcription of Th2-specific genes by GATA3,” Journal of Immunology, vol. 186, no. 11, pp. 6378–6389, 2011. View at Publisher · View at Google Scholar
  133. M. D. Siegel, D. H. Zhang, P. Ray, and A. Ray, “Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements,” Journal of Biological Chemistry, vol. 270, no. 41, pp. 24548–24555, 1995. View at Publisher · View at Google Scholar · View at Scopus
  134. M. Yamashita, M. Ukai-Tadenuma, M. Kimura et al., “Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus,” Journal of Biological Chemistry, vol. 277, no. 44, pp. 42399–42408, 2002. View at Publisher · View at Google Scholar · View at Scopus
  135. S. Agarwal, O. Avni, and A. Rao, “Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo,” Immunity, vol. 12, no. 6, pp. 643–652, 2000. View at Google Scholar · View at Scopus
  136. J. Zhu, J. Cote-Sierra, L. Guo, and W. E. Paul, “Stat5 activation plays a critical role in Th2 differentiation,” Immunity, vol. 19, no. 5, pp. 739–748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  137. L. M. Heltemes-Harris, M. J.L. Willette, K. B. Vang, and M. A. Farrar, “The role of STAT5 in the development, function, and transformation of B and T lymphocytes,” Annals of the New York Academy of Sciences, vol. 1217, no. 1, pp. 18–31, 2011. View at Publisher · View at Google Scholar
  138. M. H. Kaplan, U. Schindler, S. T. Smiley, and M. J. Grusby, “Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells,” Immunity, vol. 4, no. 3, pp. 313–319, 1996. View at Publisher · View at Google Scholar · View at Scopus
  139. H. Takeda, T. Tanaka, W. Shi et al., “Essential role of Stat6 in IL-4 signalling,” Nature, vol. 380, no. 6575, pp. 627–630, 1996. View at Publisher · View at Google Scholar · View at Scopus
  140. J. Zhu, L. Guo, C. J. Watson, J. Hu-Li, and W. E. Paul, “Stat6 is necessary and sufficient for IL-4's role in TH2 differentiation and cell expansion,” Journal of Immunology, vol. 166, no. 12, pp. 7276–7281, 2001. View at Google Scholar · View at Scopus
  141. N. Van Panhuys, S. C. Tang, M. Prout et al., “In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 34, pp. 12423–12428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  142. Q. Yu, A. Sharma, S. Y. Oh et al., “T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-γ,” Nature Immunology, vol. 10, no. 9, pp. 992–999, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. E. Maier, D. Hebenstreit, G. Posselt, P. Hammerl, A. Duschl, and J. Horejs-Hoeck, “Inhibition of suppressive T cell factor 1 (TCF-1) isoforms in naive CD4+ T cells is mediated by IL-4/STAT6 signaling,” Journal of Biological Chemistry, vol. 286, no. 2, pp. 919–928, 2011. View at Publisher · View at Google Scholar
  144. A. Sahoo, C.-G. Lee, A. Jash et al., “Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression,” Journal of Immunology, vol. 186, no. 7, pp. 4098–4109, 2011. View at Publisher · View at Google Scholar
  145. G. L. Stritesky, R. Muthukrishnan, S. Sehra et al., “The Transcription Factor STAT3 Is Required for T Helper 2 Cell Development,” Immunity, vol. 34, no. 1, pp. 39–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. I. I. Ivanov, B. S. McKenzie, L. Zhou et al., “The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells,” Cell, vol. 126, no. 6, pp. 1121–1133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  147. X. O. Yang, B. P. Pappu, R. Nurieva et al., “T Helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ,” Immunity, vol. 28, no. 1, pp. 29–39, 2008. View at Publisher · View at Google Scholar
  148. L. A. Solt, N. Kumar, P. Nuhant et al., “Suppression of T H 17 differentiation and autoimmunity by a synthetic ROR ligand,” Nature, vol. 472, no. 7344, pp. 491–494, 2011. View at Publisher · View at Google Scholar
  149. C. Taflin, B. Favier, J. Baudhuin et al., “Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 7, pp. 2891–2896, 2011. View at Publisher · View at Google Scholar
  150. L. Zhou, I. I. Ivanov, R. Spolski et al., “IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways,” Nature Immunology, vol. 8, no. 9, pp. 967–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  151. R. Nurieva, X. O. Yang, G. Martinez et al., “Essential autocrine regulation by IL-21 in the generation of inflammatory T cells,” Nature, vol. 448, no. 7152, pp. 480–483, 2007. View at Publisher · View at Google Scholar · View at Scopus
  152. X. O. Yang, A. D. Panopoulos, R. Nurieva et al., “STAT3 regulates cytokine-mediated generation of inflammatory helper T cells,” Journal of Biological Chemistry, vol. 282, no. 13, pp. 9358–9363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  153. S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  154. J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, “Foxp3 programs the development and function of CD4+CD25+ regulatory T cells,” Nature Immunology, vol. 4, no. 4, pp. 330–336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  155. M. E. Brunkow, E. W. Jeffery, K. A. Hjerrild et al., “Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse,” Nature Genetics, vol. 27, no. 1, pp. 68–73, 2001. View at Publisher · View at Google Scholar · View at Scopus
  156. C. L. Bennett, J. Christie, F. Ramsdell et al., “The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3,” Nature Genetics, vol. 27, no. 1, pp. 20–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  157. M. A. Gavin, J. P. Rasmussen, J. D. Fontenot et al., “Foxp3-dependent programme of regulatory T-cell differentiation,” Nature, vol. 445, no. 7129, pp. 771–775, 2007. View at Publisher · View at Google Scholar · View at Scopus
  158. S. Z. Josefowicz and A. Rudensky, “Control of Regulatory T Cell Lineage Commitment and Maintenance,” Immunity, vol. 30, no. 5, pp. 616–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  159. Y. Y. Wan and R. A. Flavell, “Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression,” Nature, vol. 445, no. 7129, pp. 766–770, 2007. View at Publisher · View at Google Scholar · View at Scopus
  160. L. M. Williams and A. Y. Rudensky, “Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3,” Nature Immunology, vol. 8, no. 3, pp. 277–284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  161. M. Feuerer, J. A. Hill, D. Mathis, and C. Benoist, “Foxp3+ regulatory T cells: differentiation, specification, subphenotypes,” Nature Immunology, vol. 10, no. 7, pp. 689–695, 2009. View at Publisher · View at Google Scholar · View at Scopus
  162. W. Lin, D. Haribhai, L. M. Relland et al., “Regulatory T cell development in the absence of functional Foxp3,” Nature Immunology, vol. 8, no. 4, pp. 359–368, 2007. View at Publisher · View at Google Scholar · View at Scopus
  163. J. A. Hill, M. Feuerer, K. Tash et al., “Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature,” Immunity, vol. 27, no. 5, pp. 786–800, 2007. View at Publisher · View at Google Scholar · View at Scopus
  164. A. S. Adamson, K. Collins, A. Laurence, and J. J. O'Shea, “The Current STATus of lymphocyte signaling: new roles for old players,” Current Opinion in Immunology, vol. 21, no. 2, pp. 161–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. T. S. Davidson, R. J. DiPaolo, J. Andersson, and E. M. Shevach, “Cutting edge: IL-2 is essential for TGF-β-mediated induction of Foxp3+ T regulatory cells,” Journal of Immunology, vol. 178, no. 7, pp. 4022–4026, 2007. View at Google Scholar · View at Scopus
  166. M. A. Burchill, J. Yang, C. Vogtenhuber, B. R. Blazar, and M. A. Farrar, “IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells,” Journal of Immunology, vol. 178, no. 1, pp. 280–290, 2007. View at Google Scholar
  167. M. A. Burchill, J. Yang, K. B. Vang et al., “Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire,” Immunity, vol. 28, no. 1, pp. 112–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  168. Z. Yao, Y. Kanno, M. Kerenyi et al., “Nonredundant roles for Stat5a/b in directly regulating Foxp,” Blood, vol. 109, no. 10, pp. 4368–4375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  169. C. W. J. Lio and C. S. Hsieh, “A two-step process for thymic regulatory T cell development,” Immunity, vol. 28, no. 1, pp. 100–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  170. D. K. Sojka and D. J. Fowell, “Regulatory T cells inhibit acute IFN-γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 45, pp. 18336–18341, 2011. View at Publisher · View at Google Scholar
  171. T. Chtanova, S. G. Tangye, R. Newton et al., “T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells,” Journal of Immunology, vol. 173, no. 1, pp. 68–78, 2004. View at Google Scholar · View at Scopus
  172. D. Yu, S. Rao, L. M. Tsai et al., “The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment,” Immunity, vol. 31, no. 3, pp. 457–468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  173. R. I. Nurieva, Y. Chung, G. J. Martinez et al., “Bcl6 mediates the development of T follicular helper cells,” Science, vol. 325, no. 5943, pp. 1001–1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  174. R. J. Johnston, A. C. Poholek, D. DiToro et al., “Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation,” Science, vol. 325, no. 5943, pp. 1006–1010, 2009. View at Publisher · View at Google Scholar · View at Scopus
  175. F. Eddahri, S. Denanglaire, F. Bureau et al., “Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities,” Blood, vol. 113, no. 11, pp. 2426–2433, 2009. View at Publisher · View at Google Scholar · View at Scopus
  176. J. Rolf, K. Fairfax, and M. Turner, “Signaling pathways in T follicular helper cells,” Journal of Immunology, vol. 184, no. 12, pp. 6563–6568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  177. G. T. Belz and A. Kallies, “Effector and memory CD8+ T cell differentiation: toward a molecular understanding of fate determination,” Current Opinion in Immunology, vol. 22, no. 3, pp. 279–285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. P. A. Shrikant, R. Rao, Q. Li et al., “Regulating functional cell fates in CD8 T cells,” Immunologic Research, vol. 46, no. 1–3, pp. 12–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. N. Zhang and M. Bevan, “CD8+ T Cells: foot Soldiers of the Immune System,” Immunity, vol. 35, no. 2, pp. 161–168, 2011. View at Publisher · View at Google Scholar
  180. F. Sallusto, D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia, “Two subsets of memory T lymphocytes with distinct homing potentials and effector functions,” Nature, vol. 401, no. 6754, pp. 708–712, 1999. View at Publisher · View at Google Scholar · View at Scopus
  181. L. Gattinoni, E. Lugli, Y. Ji et al., “A human memory T cell subset with stem cell-like properties,” Nature Medicine, vol. 17, no. 10, pp. 1290–1297, 2011. View at Publisher · View at Google Scholar
  182. Y. Zhang, G. Joe, E. Hexner, J. Zhu, and S. G. Emerson, “Host-reactive CD8+ memory stem cells in graft-versus-host disease,” Nature Medicine, vol. 11, no. 12, pp. 1299–1305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  183. L. Gattinoni, X. S. Zhong, D. C. Palmer et al., “Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells,” Nature Medicine, vol. 15, no. 7, pp. 808–813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  184. M. Prlic and M. J. Bevan, “Cutting edge: β-catenin is dispensable for T cell effector differentiation, Memory formation, and recall responses,” Journal of Immunology, vol. 187, no. 4, pp. 1542–1546, 2011. View at Publisher · View at Google Scholar
  185. K. Schepers, E. Swart, J. W. J. Van Heijst et al., “Dissecting T cell lineage relationships by cellular barcoding,” Journal of Experimental Medicine, vol. 205, no. 10, pp. 2309–2318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  186. E. Teixeiro, M. A. Daniels, S. E. Hamilton et al., “Different T cell receptor signals determine CD8+ memory versus effector development,” Science, vol. 323, no. 5913, pp. 502–505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  187. J. T. Chang, V. R. Palanivel, I. Kinjyo et al., “Asymmetric T lymphocyte division in the initiation of adaptive immune responses,” Science, vol. 315, no. 5819, pp. 1687–1691, 2007. View at Publisher · View at Google Scholar · View at Scopus
  188. C. Gerlach, J. W. J. Van Heijst, E. Swart et al., “One naive T cell, multiple fates in CD8+ T cell differentiation,” Journal of Experimental Medicine, vol. 207, no. 6, pp. 1235–1246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  189. C. Stemberger, K. M. Huster, M. Koffler et al., “A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets,” Immunity, vol. 27, no. 6, pp. 985–997, 2007. View at Publisher · View at Google Scholar · View at Scopus
  190. V. Kalia, S. Sarkar, S. Subramaniam, W. N. Haining, K. A. Smith, and R. Ahmed, “Prolonged interleukin-2Rα expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo,” Immunity, vol. 32, no. 1, pp. 91–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  191. M. E. Pipkin, J. A. Sacks, F. Cruz-Guilloty, M. G. Lichtenheld, M. J. Bevan, and A. Rao, “Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells,” Immunity, vol. 32, no. 1, pp. 79–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  192. J. Chang, M. Ciocca, I. Kinjyo et al., “Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division,” Immunity, vol. 34, no. 4, pp. 492–504, 2011. View at Publisher · View at Google Scholar
  193. S. J. Szabo, B. M. Sullivan, C. Sternmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher, “Distinct effects of T-bet in Th1 lineage commitment and IFN-γ production in CD4 and CD8 T cells,” Science, vol. 295, no. 5553, pp. 338–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  194. C. J. J. Yeo and D. T. Fearon, “T-bet-mediated differentiation of the activated CD8+ T cell,” European Journal of Immunology, vol. 41, no. 1, pp. 60–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  195. M. Heffner and D. T. Fearon, “Loss of T cell receptor-induced Bmi-1 in the KLRG1+ senescent CD8+ T lymphocyte,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 33, pp. 13414–13419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  196. E. L. Pearce, A. C. Mullen, G. A. Martins et al., “Control of effector CD8+ T cell function by the transcription factor eomesodermin,” Science, vol. 302, no. 5647, pp. 1041–1043, 2003. View at Publisher · View at Google Scholar · View at Scopus
  197. A. Banerjee, S. M. Gordon, A. M. Intlekofer et al., “Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche,” Journal of Immunology, vol. 185, no. 9, pp. 4988–4992, 2010. View at Publisher · View at Google Scholar · View at Scopus
  198. N. S. Joshi, W. Cui, A. Chandele et al., “Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor,” Immunity, vol. 27, no. 2, pp. 281–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  199. A. M. Intlekofer, N. Takemoto, C. Kao et al., “Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells,” Journal of Experimental Medicine, vol. 204, no. 9, pp. 2015–2021, 2007. View at Publisher · View at Google Scholar · View at Scopus
  200. R. L. Rutishauser, G. A. Martins, S. Kalachikov et al., “Transcriptional repressor Blimp-1 promotes CD8+ T cell terminal differentiation and represses the acquisition of central memory T cell properties,” Immunity, vol. 31, no. 2, pp. 296–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  201. A. Kallies, A. Xin, G. T. Belz, and S. L. Nutt, “Blimp-1 transcription factor is required for the differentiation of effector CD8+ T cells and memory responses,” Immunity, vol. 31, no. 2, pp. 283–295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  202. A. Xin, S. L. Nutt, G. T. Belz, and A. Kallies, “Blimp1: driving terminal differentiation to a T,” Advances in Experimental Medicine and Biology, vol. 780, pp. 85–100, 2011. View at Publisher · View at Google Scholar
  203. S. Crotty, R. J. Johnston, and S. P. Schoenberger, “Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation,” Nature Immunology, vol. 11, no. 2, pp. 114–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  204. H. Shin, S. D. Blackburn, A. M. Intlekofer et al., “A role for the transcriptional repressor Blimp-1 in CD8+ T cell exhaustion during chronic viral infection,” Immunity, vol. 31, no. 2, pp. 309–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  205. P. Tripathi, S. Kurtulus, S. Wojciechowski et al., “STAT5 is critical to maintain effector CD8+T cell responses,” Journal of Immunology, vol. 185, no. 4, pp. 2116–2124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  206. T. W. Hand, W. Cui, Y. W. Jung et al., “Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 38, pp. 16601–16606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  207. K. V. Anderson, L. Bokla, and C. Nusslein-Volhard, “Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product,” Cell, vol. 42, no. 3, pp. 791–798, 1985. View at Google Scholar · View at Scopus
  208. K. V. Anderson, G. Jurgens, and C. Nusslein-Volhard, “Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product,” Cell, vol. 42, no. 3, pp. 779–789, 1985. View at Google Scholar · View at Scopus
  209. B. Lemaitre, E. Nicolas, L. Michaut, J. M. Reichhart, and J. A. Hoffmann, “The dorsoventral regulatory gene cassette spatzle/Toll/Cactus controls the potent antifungal response in Drosophila adults,” Cell, vol. 86, no. 6, pp. 973–983, 1996. View at Publisher · View at Google Scholar · View at Scopus
  210. C. Chiang and P. A. Beachy, “Expression of a novel Toll-like gene spans the parasegment boundary and contributes to hedgehog function in the adult eye of Drosophila,” Mechanisms of Development, vol. 47, no. 3, pp. 225–239, 1994. View at Publisher · View at Google Scholar · View at Scopus
  211. F. L. Rock, G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan, “A family of human receptors structurally related to Drosophila Toll,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 2, pp. 588–593, 1998. View at Publisher · View at Google Scholar · View at Scopus
  212. T. Kawai and S. Akira, “The role of pattern-recognition receptors in innate immunity: update on toll-like receptors,” Nature Immunology, vol. 11, no. 5, pp. 373–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  213. Z. L. Chang, “Important aspects of Toll-like receptors, ligands and their signaling pathways,” Inflammation Research, vol. 59, no. 10, pp. 791–808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  214. A. I. Tukhvatulin, D. Y. Logunov, D. N. Shcherbinin et al., “Toll-like receptors and their adapter molecules,” Biochemistry, vol. 75, no. 9, pp. 1098–1114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  215. S. Carpenter and L. A. J. O'Neill, “Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins,” Biochemical Journal, vol. 422, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  216. A. L. Blasius and B. Beutler, “Intracellular Toll-like receptors,” Immunity, vol. 32, no. 3, pp. 305–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  217. A. F. McGettrick and L. A. O'Neill, “Localisation and trafficking of Toll-like receptors: an important mode of regulation,” Current Opinion in Immunology, vol. 22, no. 1, pp. 20–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  218. S. E. Ewald, B. L. Lee, L. Lau et al., “The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor,” Nature, vol. 456, no. 7222, pp. 658–662, 2008. View at Publisher · View at Google Scholar · View at Scopus
  219. C. A. Leifer, J. C. Brooks, K. Hoelzer et al., “Cytoplasmic targeting motifs control localization of toll-like receptor 9,” Journal of Biological Chemistry, vol. 281, no. 46, pp. 35585–35592, 2006. View at Publisher · View at Google Scholar · View at Scopus
  220. T. Nishiya, E. Kajita, S. Miwa, and A. L. DeFranco, “TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements,” Journal of Biological Chemistry, vol. 280, no. 44, pp. 37107–37117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  221. B. Park, M. M. Brinkmann, E. Spooner, C. C. Lee, Y. M. Kim, and H. L. Ploegh, “Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9,” Nature Immunology, vol. 9, no. 12, pp. 1407–1414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  222. A. Chockalingam, J. C. Brooks, J. L. Cameron, L. K. Blum, and C. A. Leifer, “TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA,” Immunology and Cell Biology, vol. 87, no. 3, pp. 209–217, 2009. View at Publisher · View at Google Scholar · View at Scopus
  223. Y. M. Kim, M. M. Brinkmann, M. E. Paquet, and H. L. Ploegh, “UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes,” Nature, vol. 452, no. 7184, pp. 234–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  224. M. M. Brinkmann, E. Spooner, K. Hoebe, B. Beutler, H. L. Ploegh, and Y. M. Kim, “The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling,” Journal of Cell Biology, vol. 177, no. 2, pp. 265–275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  225. R. Fukui, S. I. Saitoh, F. Matsumoto et al., “Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing,” Journal of Experimental Medicine, vol. 206, no. 6, pp. 1339–1350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  226. K. Tabeta, K. Hoebe, E. M. Janssen et al., “The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9,” Nature Immunology, vol. 7, no. 2, pp. 156–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  227. S. Bauer, T. Müller, and S. Hamm, “Pattern recognition by Toll-like receptors,” Advances in experimental medicine and biology, vol. 653, pp. 15–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  228. H. Wesche, W. J. Henzel, W. Shillinglaw, S. Li, and Z. Cao, “MyD88: an adapter that recruits IRAK to the IL-1 receptor complex,” Immunity, vol. 7, no. 6, pp. 837–847, 1997. View at Publisher · View at Google Scholar · View at Scopus
  229. H. Oshiumi, M. Matsumoto, K. Funami, T. Akazawa, and T. Seya, “TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction,” Nature Immunology, vol. 4, no. 2, pp. 161–167, 2003. View at Publisher · View at Google Scholar · View at Scopus
  230. M. Yamamoto, S. Sato, K. Mori et al., “Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling,” Journal of Immunology, vol. 169, no. 12, pp. 6668–6672, 2002. View at Google Scholar · View at Scopus
  231. T. Horng, G. M. Barton, and R. Medzhitov, “TIRAP: an adapter molecule in the Toll signaling pathway,” Nature Immunology, vol. 2, no. 9, pp. 835–841, 2001. View at Publisher · View at Google Scholar · View at Scopus
  232. K. A. Fitzgerald, E. M. Palsson-Mcdermott, A. G. Bowie et al., “Mal (MyD88-adapter-like) is required for toll-like recepfor-4 signal transduction,” Nature, vol. 413, no. 6851, pp. 78–83, 2001. View at Publisher · View at Google Scholar · View at Scopus
  233. M. Yamamoto, S. Sato, H. Hemmi et al., “TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway,” Nature Immunology, vol. 4, no. 11, pp. 1144–1150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  234. P. Gray, A. Dunne, C. Brikos, C. A. Jefferies, S. L. Doyle, and L. A. J. O'Neill, “MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction,” Journal of Biological Chemistry, vol. 281, no. 15, pp. 10489–10495, 2006. View at Publisher · View at Google Scholar · View at Scopus
  235. N. Suzuki, S. Suzuki, G. S. Duncan et al., “Severe impairment of interleukin-1 and toll-like receptor signalling in mice lacking IRAK-4,” Nature, vol. 416, no. 6882, pp. 750–754, 2002. View at Publisher · View at Google Scholar · View at Scopus
  236. T. Kawagoe, S. Sato, K. Matsushita et al., “Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2,” Nature Immunology, vol. 9, no. 6, pp. 684–691, 2008. View at Publisher · View at Google Scholar · View at Scopus
  237. M. Muzio, G. Natoli, S. Saccani, M. Levrero, and A. Mantovani, “The human toll signaling pathway: divergence of nuclear factor κb and jnk/sapk activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6),” Journal of Experimental Medicine, vol. 187, no. 12, pp. 2097–2101, 1998. View at Publisher · View at Google Scholar · View at Scopus
  238. F. Tokunaga, S. I. Sakata, Y. Saeki et al., “Involvement of linear polyubiquitylation of NEMO in NF-κB activation,” Nature Cell Biology, vol. 11, no. 2, pp. 123–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  239. S. Rahighi, F. Ikeda, M. Kawasaki et al., “Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation,” Cell, vol. 136, no. 6, pp. 1098–1109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  240. T. D. Prickett, J. Ninomiya-Tsuji, P. Broglie et al., “TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-κB,” Journal of Biological Chemistry, vol. 283, no. 28, pp. 19245–19254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  241. G. Jin, A. Klika, M. Callahan et al., “Identification of a human NF-κB-activating protein, TAB3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 7, pp. 2028–2033, 2004. View at Publisher · View at Google Scholar · View at Scopus
  242. A. Takaoka, H. Yanai, S. Kondo et al., “Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors,” Nature, vol. 434, no. 7030, pp. 243–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  243. H. Negishi, Y. Ohba, H. Yanai et al., “Negative regulation of Toll-like-receptor signaling by IRF-4,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 44, pp. 15989–15994, 2005. View at Publisher · View at Google Scholar · View at Scopus
  244. P. H. Tseng, A. Matsuzawa, W. Zhang, T. Mino, D. A. A. Vignali, and M. Karin, “Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type i interferons and proinflammatory cytokines,” Nature Immunology, vol. 11, no. 1, pp. 70–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  245. H. Häcker, V. Redecke, B. Blagoev et al., “Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6,” Nature, vol. 439, no. 7073, pp. 204–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  246. G. Oganesyan, S. K. Saha, B. Guo et al., “Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response,” Nature, vol. 439, no. 7073, pp. 208–211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  247. K. Honda, Y. Ohba, H. Yanai et al., “Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction,” Nature, vol. 434, no. 7036, pp. 1035–1040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  248. K. Honda, H. Yanai, H. Negishi et al., “IRF-7 is the master regulator of type-I interferon-dependent immune responses,” Nature, vol. 434, no. 7034, pp. 772–777, 2005. View at Publisher · View at Google Scholar · View at Scopus
  249. C. Guiducci, C. Ghirelli, M. A. Marloie-Provost et al., “PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation,” Journal of Experimental Medicine, vol. 205, no. 2, pp. 315–322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  250. I. Zanoni and F. Granucci, “Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors,” Journal of Molecular Medicine, vol. 88, no. 9, pp. 873–880, 2010. View at Publisher · View at Google Scholar · View at Scopus
  251. N. Kadowaki, S. Ho, S. Antonenko et al., “Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens,” Journal of Experimental Medicine, vol. 194, no. 6, pp. 863–869, 2001. View at Publisher · View at Google Scholar · View at Scopus
  252. M. Muzio, D. Bosisio, N. Polentarutti et al., “Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells,” Journal of Immunology, vol. 164, no. 11, pp. 5998–6004, 2000. View at Google Scholar · View at Scopus
  253. A. Krug, A. Towarowski, S. Britsch et al., “Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with Cd40 ligand to induce high amounts of IL-12,” European Journal of Immunology, vol. 31, no. 10, pp. 3026–3037, 2001. View at Publisher · View at Google Scholar · View at Scopus
  254. V. Hornung, S. Rothenfusser, S. Britsch et al., “Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides,” Journal of Immunology, vol. 168, no. 9, pp. 4531–4537, 2002. View at Google Scholar
  255. D. Schattenberg, M. Schott, G. Reindl et al., “Response of human monocyte-derived dendritic cells to immunostimulatory DNA,” European Journal of Immunology, vol. 30, no. 10, pp. 2824–2831, 2000. View at Publisher · View at Google Scholar · View at Scopus
  256. A. D. Edwards, S. S. Diebold, E. M.C. Slack et al., “Toll-like receptor expression in murine DC subsets: lack of TLR7 expresion of CD8α+ DC correlates with unresponsiveness to imidazoquinolines,” European Journal of Immunology, vol. 33, no. 4, pp. 827–833, 2003. View at Publisher · View at Google Scholar
  257. T. Seya, H. Shime, T. Ebihara, H. Oshiumi, and M. Matsumoto, “Pattern recognition receptors of innate immunity and their application to tumor immunotherapy,” Cancer Science, vol. 101, no. 2, pp. 313–320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  258. M. Chang, W. Jin, and S. C. Sun, “Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production,” Nature Immunology, vol. 10, no. 10, pp. 1089–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  259. N. Cusson-Hermance, S. Khurana, T. H. Lee, K. A. Fitzgerald, and M. A. Kelliher, “Rip1 mediates the trif-dependent Toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation,” Journal of Biological Chemistry, vol. 280, no. 44, pp. 36560–36566, 2005. View at Publisher · View at Google Scholar · View at Scopus
  260. B. Jin, T. Sun, X.-H. Yu et al., “Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 690438, 17 pages, 2010. View at Publisher · View at Google Scholar
  261. M. Sasai, H. Oshiumi, M. Matsumoto et al., “Cutting edge: NF-κB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation,” Journal of Immunology, vol. 174, no. 1, pp. 27–30, 2005. View at Google Scholar · View at Scopus
  262. W. J. Kaiser and M. K. Offermann, “Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif,” Journal of Immunology, vol. 174, no. 8, pp. 4942–4952, 2005. View at Google Scholar · View at Scopus
  263. E. Vercammen, J. Staal, and R. Beyaert, “Sensing of viral infection and activation of innate immunity by toll-like receptor 3,” Clinical Microbiology Reviews, vol. 21, no. 1, pp. 13–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  264. K. J. Han, Y. Yang, L. G. Xu, and H. B. Shu, “Analysis of a TIR-less splice variant of TRIF reveals an unexpected mechanism of TLR3-mediated signaling,” Journal of Biological Chemistry, vol. 285, no. 17, pp. 12543–12550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  265. S. N. Sarkar, K. L. Peters, C. P. Elco, S. Sakamoto, S. Pal, and G. C. Sen, “Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling,” Nature Structural and Molecular Biology, vol. 11, no. 11, pp. 1060–1067, 2004. View at Publisher · View at Google Scholar · View at Scopus
  266. S. N. Sarkar, C. P. Elco, K. L. Peters, S. Chattopadhyay, and G. C. Sen, “Two tyrosine residues of toll-like receptor 3 trigger different steps of NF-κB activation,” Journal of Biological Chemistry, vol. 282, no. 6, pp. 3423–3427, 2007. View at Publisher · View at Google Scholar · View at Scopus
  267. I. B. Johnsen, T. T. Nguyen, M. Ringdal et al., “Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling,” EMBO Journal, vol. 25, no. 14, pp. 3335–3346, 2006. View at Publisher · View at Google Scholar · View at Scopus
  268. G. Liu, L. Zhang, and Y. Zhao, “Modulation of immune responses through direct activation of Toll-like receptors to T cells,” Clinical and Experimental Immunology, vol. 160, no. 2, pp. 168–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  269. O. Takeuchi and S. Akira, “Innate immunity to virus infection,” Immunological Reviews, vol. 227, no. 1, pp. 75–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  270. Q. Lin, C. Dong, and M. D. Cooper, “Impairment of T and B cell development by treatment with a type I interferon,” Journal of Experimental Medicine, vol. 187, no. 1, pp. 79–87, 1998. View at Publisher · View at Google Scholar · View at Scopus
  271. T. Tsukiyama, N. Ishida, M. Shirane et al., “Down-regulation of p27Kip1 expression is required for development and function of T cells,” Journal of Immunology, vol. 166, no. 1, pp. 304–312, 2001. View at Google Scholar · View at Scopus
  272. M.-L. Baron, D. Gauchat, R. L. Motte-Mohs et al., “TLR ligand-induced type I IFNs affect thymopoiesis,” Journal of Immunology, vol. 180, no. 11, pp. 7134–7146, 2008. View at Google Scholar
  273. T. Démoulins, A. Abdallah, N. Kettaf et al., “Reversible blockade of thymic output: an inherent part of TLR ligand-mediated immune response,” Journal of Immunology, vol. 181, no. 10, pp. 6757–6769, 2008. View at Google Scholar
  274. D. Anz, R. Thaler, N. Stephan et al., “Activation of melanoma differentiation-associated gene 5 causes rapid involution of the thymus,” Journal of Immunology, vol. 182, no. 10, pp. 6044–6050, 2009. View at Publisher · View at Google Scholar · View at Scopus
  275. M. J. Billard, A. L. Gruver, and G. D. Sempowski, “Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses,” PLoS One, vol. 6, no. 3, Article ID e17940, 2011. View at Publisher · View at Google Scholar
  276. T. Kawai and S. Akira, “Toll-like receptors and their crosstalk with other innate receptors in infection and immunity,” Immunity, vol. 34, no. 5, pp. 637–650, 2011. View at Publisher · View at Google Scholar
  277. M. L. Salem, “Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses,” Immunology Letters, vol. 137, no. 1-2, pp. 9–14, 2011. View at Publisher · View at Google Scholar
  278. R. Kulkarni, S. Behboudi, and S. Sharif, “Insights into the role of Toll-like receptors in modulation of T cell responses,” Cell and Tissue Research, vol. 343, no. 1, pp. 141–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  279. K. A. Zarember and P. J. Godowski, “Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines,” Journal of Immunology, vol. 168, no. 2, pp. 554–561, 2002. View at Google Scholar · View at Scopus
  280. S. E. Applequist, R. P. A. Wallin, and H. G. Ljunggren, “Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines,” International Immunology, vol. 14, no. 9, pp. 1065–1074, 2002. View at Google Scholar · View at Scopus
  281. M. Komai-Koma, L. Jones, G. S. Ogg, D. Xu, and F. Y. Liew, “TLR2 is expressed activated T cells as a costimulatory receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 3029–3034, 2004. View at Publisher · View at Google Scholar · View at Scopus
  282. M. Schnare, G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov, “Toll-like receptors control activation of adaptive immune responses,” Nature Immunology, vol. 2, no. 10, pp. 947–950, 2001. View at Publisher · View at Google Scholar · View at Scopus
  283. S. Bauer, D. Hangel, and P. Yu, “Immunobiology of toll-like receptors in allergic disease,” Immunobiology, vol. 212, no. 6, pp. 521–533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  284. D. E. Gaddis, S. M. Michalek, and J. Katz, “TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B,” Journal of Immunology, vol. 186, no. 10, pp. 5772–5783, 2011. View at Publisher · View at Google Scholar
  285. A. F. Heiseke, A. C. Faul, H. Lehr et al., “CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cellmediated protection from colitis,” Gastroenterology, vol. 142, no. 2, pp. 335–345, 2012. View at Publisher · View at Google Scholar
  286. J. Sun and E. J. Pearce, “Suppression of early IL-4 production underlies the failure of CD4 T cells activated by TLR-stimulated dendritic cells to differentiate into Th2 cells,” Journal of Immunology, vol. 178, no. 3, pp. 1635–1644, 2007. View at Google Scholar · View at Scopus
  287. S. C. Eisenbarth, D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly, “Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen,” Journal of Experimental Medicine, vol. 196, no. 12, pp. 1645–1651, 2002. View at Publisher · View at Google Scholar · View at Scopus
  288. D.-H. Kim, J.-C. Lee, S. Kim et al., “Inhibition of autoimmune diabetes by TLR2 tolerance,” Journal of Immunology, vol. 187, no. 10, pp. 5211–5220, 2011. View at Publisher · View at Google Scholar
  289. J. Patenaude, M. D'Elia, G. Côté-Maurais, and J. Bernier, “LPS response and endotoxin tolerance in Flt-3L-induced bone marrow-derived dendritic cells,” Cellular Immunology, vol. 271, no. 1, pp. 184–191, 2011. View at Publisher · View at Google Scholar
  290. M. Schmaler, N. J. Jann, F. Ferracin, and R. Landmann, “T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation,” Journal of Immunology, vol. 186, no. 1, pp. 443–452, 2011. View at Publisher · View at Google Scholar
  291. M. H. Wenink, K. C. M. Santegoets, J. C. A. Broen et al., “TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the Type I IFN amplification loop,” Journal of Immunology, vol. 183, no. 11, pp. 6960–6970, 2009. View at Publisher · View at Google Scholar · View at Scopus
  292. C. Pasare and R. Medzhitov, “Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells,” Science, vol. 299, no. 5609, pp. 1033–1036, 2003. View at Publisher · View at Google Scholar · View at Scopus
  293. D. Hackl, J. Loschko, T. Sparwasser, W. Reindl, and A. B. Krug, “Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs,” European Journal of Immunology, vol. 41, no. 5, pp. 1334–1343, 2011. View at Publisher · View at Google Scholar
  294. L. Pham Van, E. Bardel, S. Gregoire et al., “Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms,” European Journal of Immunology, vol. 41, no. 7, pp. 1992–1999, 2011. View at Publisher · View at Google Scholar
  295. A. Boonstra, C. Asselin-Paturel, M. Gilliet et al., “Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation,” Journal of Experimental Medicine, vol. 197, no. 1, pp. 101–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  296. S. R. Myneni, R. P. Settem, T. D. Connell, A. D. Keegan, S. L. Gaffen, and A. Sharma, “TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss,” Journal of Immunology, vol. 187, no. 1, pp. 501–509, 2011. View at Publisher · View at Google Scholar
  297. J. P. McAleer and A. T. Vella, “Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide,” Trends in Immunology, vol. 31, no. 11, pp. 429–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  298. M. N. Alonso, M. T. Wong, A. L. Zhang et al., “T H1, T H2, and T H17 cells instruct monocytes to differentiate into specialized dendritic cell subsets,” Blood, vol. 118, no. 12, pp. 3311–3320, 2011. View at Publisher · View at Google Scholar
  299. L. L. Lanier, “DAP10- and DAP12-associated receptors in innate immunity,” Immunological Reviews, vol. 227, no. 1, pp. 150–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  300. C.-L. Chu, Y.-L. Yu, K.-Y. Shen, C. A. Lowell, L. L. Lanier, and J. A. Hamerman, “Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRγ,” European Journal of Immunology, vol. 38, no. 1, pp. 166–173, 2008. View at Publisher · View at Google Scholar
  301. W. Cao, D. B. Rosen, T. Ito et al., “Plasmacytoid dendritic cell-specific receptor ILT7-FcεRIγ inhibits Toll-like receptor-induced interferon production,” Journal of Experimental Medicine, vol. 203, no. 6, pp. 1399–1405, 2006. View at Publisher · View at Google Scholar
  302. H. Ito and J. A. Hamerman, “TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells,” European Journal of Immunology, vol. 42, no. 1, pp. 176–185, 2012. View at Publisher · View at Google Scholar
  303. A. H. Rahman, D. K. Taylor, and L. A. Turka, “The contribution of direct TLR signaling to T cell responses,” Immunologic Research, vol. 45, no. 1, pp. 25–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  304. V. Sobek, N. Birkner, I. Falk et al., “Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease,” Arthritis Research & Therapy, vol. 6, no. 5, pp. R433–446, 2004. View at Google Scholar · View at Scopus
  305. A. E. Gelman, J. Zhang, Y. Choi, and L. A. Turka, “Toll-like receptor ligands directly promote activated CD4+ T cell survival,” Journal of Immunology, vol. 172, no. 10, pp. 6065–6073, 2004. View at Google Scholar · View at Scopus
  306. H. Liu, M. Komai-Koma, D. Xu, and F. Y. Liew, “Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 18, pp. 7048–7053, 2006. View at Publisher · View at Google Scholar · View at Scopus
  307. C. L. Lancioni, J. J. Thomas, and R. E. Rojas, “Activation requirements and responses to TLR ligands in human CD4+ T cells: comparison of two T cell isolation techniques,” Journal of Immunological Methods, vol. 344, no. 1, pp. 15–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  308. A. Cottalorda, C. Verschelde, A. Marçais et al., “TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation,” European Journal of Immunology, vol. 36, no. 7, pp. 1684–1693, 2006. View at Publisher · View at Google Scholar
  309. B. C. Mercier, A. Cottalorda, C. A. Coupet, J. Marvel, and N. Bonnefoy-Bérard, “TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal,” Journal of Immunology, vol. 182, no. 4, pp. 1860–1867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  310. A. Cottalorda, B. C. Mercier, F. M. Mbitikon-Kobo et al., “TLR2 engagement on memory CD8+ T cells improves their cytokine-mediated proliferation and IFN-γ secretion in the absence of Ag,” European Journal of Immunology, vol. 39, no. 10, pp. 2673–2681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  311. M. Quigley, J. Martinez, X. Huang, and Y. Yang, “A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection,” Blood, vol. 113, no. 10, pp. 2256–2264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  312. A. E. Gelman, D. F. LaRosa, J. Zhang et al., “The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation,” Immunity, vol. 25, no. 5, pp. 783–793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  313. C. K. Holm, C. C. Petersen, M. Hvid et al., “TLR3 ligand polyinosinic: polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells,” Journal of Immunology, vol. 183, no. 7, pp. 4422–4431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  314. R. P. M. Sutmuller, M. H. M. G. M. Den Brok, M. Kramer et al., “Toll-like receptor 2 controls expansion and function of regulatory T cells,” Journal of Clinical Investigation, vol. 116, no. 2, pp. 485–494, 2006. View at Publisher · View at Google Scholar · View at Scopus
  315. H. H. Oberg, T. T. H. Ly, S. Ussat, T. Meyer, D. Kabelitz, and D. Wesch, “Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands,” Journal of Immunology, vol. 184, no. 9, pp. 4733–4740, 2010. View at Publisher · View at Google Scholar · View at Scopus
  316. Y. G. Tsai, K. D. Yang, D. M. Niu, J. W. Chien, and C. Y. Lin, “TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy,” Journal of Immunology, vol. 184, no. 12, pp. 7229–7237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  317. W. W.C. van Maren, S. Nierkens, L. W. Toonen, J. M. Bolscher, R. P.M. Sutmuller, and G. J. Adema, “Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation,” BMC Immunology, vol. 12, article 23, 2011. View at Publisher · View at Google Scholar
  318. J. M. Reynolds, B. P. Pappu, J. Peng et al., “Toll-like receptor 2 signaling in CD4+ T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease,” Immunity, vol. 32, no. 5, pp. 692–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  319. M. H. Nyirenda, L. Sanvito, P. J. Darlington et al., “TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function,” Journal of Immunology, vol. 187, no. 5, pp. 2278–2290, 2011. View at Publisher · View at Google Scholar
  320. M. D. Sharma, D. Y. Hou, B. Baban et al., “Reprogrammed Foxp3+ regulatory T cells provide essential help to support cross-presentation and CD8+ T cell priming in naive mice,” Immunity, vol. 33, no. 6, pp. 942–954, 2010. View at Publisher · View at Google Scholar · View at Scopus
  321. A. L. Mellor and D. H. Munn, “Physiologic control of the functional status of Foxp3+ regulatory T cells,” Journal of Immunology, vol. 186, no. 8, pp. 4535–4540, 2011. View at Publisher · View at Google Scholar
  322. X. O. Yang, R. Nurieva, G. J. Martinez et al., “Molecular antagonism and plasticity of regulatory and inflammatory T cell programs,” Immunity, vol. 29, no. 1, pp. 44–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  323. L. Li, J. Kim, and V. A. Boussiotis, “IL-1β-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells,” Journal of Immunology, vol. 185, no. 7, pp. 4148–4153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  324. R. P. M. Sutmuller, M. E. Morgan, M. G. Netea, O. Grauer, and G. J. Adema, “Toll-like receptors on regulatory T cells: expanding immune regulation,” Trends in Immunology, vol. 27, no. 8, pp. 387–393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  325. Y. Zhang, F. Luo, Y. Cai et al., “TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells,” Journal of Immunology, vol. 186, no. 4, pp. 1963–1969, 2011. View at Publisher · View at Google Scholar
  326. A. Zanin-Zhorov, L. Cahalon, G. Tal, R. Margalit, O. Lider, and I. R. Cohen, “Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 2022–2032, 2006. View at Publisher · View at Google Scholar · View at Scopus
  327. I. De Kleer, Y. Vercoulen, M. Klein et al., “CD30 discriminates heat shock protein 60-induced FOXP3+ CD4+ T cells with a regulatory phenotype,” Journal of Immunology, vol. 185, no. 4, pp. 2071–2079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  328. C. A. Wild, S. Brandau, M. Lindemann et al., “Toll-like receptors in regulatory T cells of patients with head and neck cancer,” Archives of Otolaryngology - Head and Neck Surgery, vol. 136, no. 12, pp. 1253–1259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  329. I. Caramalho, T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot, “Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide,” Journal of Experimental Medicine, vol. 197, no. 4, pp. 403–411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  330. P. Lewkowicz, N. Lewkowicz, A. Sasiak, and H. Tchórzewski, “Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death,” Journal of Immunology, vol. 177, no. 10, pp. 7155–7163, 2006. View at Google Scholar
  331. N. K. Crellin, R. V. Garcia, O. Hadisfar, S. E. Allan, T. S. Steiner, and M. K. Levings, “Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells,” Journal of Immunology, vol. 175, no. 12, pp. 8051–8059, 2005. View at Google Scholar · View at Scopus
  332. D. Kabelitz, “Expression and function of Toll-like receptors in T lymphocytes,” Current Opinion in Immunology, vol. 19, no. 1, pp. 39–45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  333. G. Peng, Z. Guo, Y. Kiniwa et al., “Immunology: Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function,” Science, vol. 309, no. 5739, pp. 1380–1384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  334. D. F. LaRosa, A. E. Gelman, A. H. Rahman, J. Zhang, L. A. Turka, and P. T. Walsh, “CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells,” Immunology Letters, vol. 108, no. 2, pp. 183–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  335. B. Baban, P. R. Chandler, M. D. Sharma et al., “IDO activates regulatory T cells and blocks their conversion into Th17-like T cells,” Journal of Immunology, vol. 183, no. 4, pp. 2475–2483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  336. M. D. Sharma, D. Y. Hou, Y. Liu et al., “Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes,” Blood, vol. 113, no. 24, pp. 6102–6111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  337. M. Tsuji, N. Komatsu, S. Kawamoto et al., “Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches,” Science, vol. 323, no. 5920, pp. 1488–1492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  338. Y. Wang, A. Souabni, R. A. Flavell, and Y. Y. Wan, “An intrinsic mechanism predisposes Foxp3-expressing regulatory T cells to Th2 conversion in vivo,” Journal of Immunology, vol. 185, no. 10, pp. 5983–5992, 2010. View at Publisher · View at Google Scholar · View at Scopus
  339. S. Vendetti, T. S. Davidson, F. Veglia et al., “Polyclonal Treg cells enhance the activity of a mucosal adjuvant,” Immunology and Cell Biology, vol. 88, no. 7, pp. 698–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  340. J. W. Yewdell, “Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses,” Immunity, vol. 25, no. 4, pp. 533–543, 2006. View at Publisher · View at Google Scholar · View at Scopus
  341. S. Siddiqui and S. Basta, “CD8+ T cell immunodominance in lymphocytic choriomeningitis virus infection is modified in the presence of toll-like receptor agonists,” Journal of Virology, vol. 85, no. 24, pp. 13224–13233, 2011. View at Publisher · View at Google Scholar
  342. J. Magarian Blander and R. Medzhitov, “Toll-dependent selection of microbial antigens for presentation by dendritic cells,” Nature, vol. 440, no. 7085, pp. 808–812, 2006. View at Publisher · View at Google Scholar · View at Scopus
  343. H. T. Ichikawa, L. P. Williams, and B. M. Segal, “Activation of APCs through CD40 or toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease,” Journal of Immunology, vol. 169, no. 5, pp. 2781–2787, 2002. View at Google Scholar · View at Scopus
  344. Y. Liu, X. Tian, W. W. Leitner et al., “Polymeric structure and host toll-like receptor 4 dictate immunogenicity of NY-ESO-1 antigen in vivo,” Journal of Biological Chemistry, vol. 286, no. 43, pp. 37077–37084, 2011. View at Publisher · View at Google Scholar
  345. A. C.C. Lin, D. Dissanayake, S. Dhanji, A. R. Elford, and P. S. Ohashi, “Different toll-like receptor stimuli have a profound impact on cytokines required to break tolerance and induce autoimmunity,” PLoS One, vol. 6, no. 9, Article ID e23940, 2011. View at Publisher · View at Google Scholar
  346. S. Chiesa, S. Morbelli, S. Morando et al., “Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 42, pp. 17384–17389, 2011. View at Publisher · View at Google Scholar
  347. S. Nierkens, M. H. Den Brok, Z. Garcia et al., “Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells,” Cancer Research, vol. 71, no. 20, pp. 6428–6437, 2011. View at Publisher · View at Google Scholar
  348. E. Shklovskaya, B. J. O'Sullivan, L. G. Ng et al., “Langerhans cells are precommitted to immune tolerance induction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 44, pp. 18049–18054, 2011. View at Publisher · View at Google Scholar
  349. A. M.G. Van Der Aar, R. De Groot, M. Sanchez-Hernandez et al., “Cutting edge: virus selectively primes human Langerhans cells for CD70 expression promoting CD8+ T cell responses,” Journal of Immunology, vol. 187, no. 7, pp. 3488–3492, 2011. View at Publisher · View at Google Scholar
  350. K. Fujimoto, T. Karuppuchamy, N. Takemura et al., “A new subset of CD103+CD8α+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity,” Journal of Immunology, vol. 186, no. 11, pp. 6287–6295, 2011. View at Publisher · View at Google Scholar
  351. C. Reis E Sousa, “Dendritic cells in a mature age,” Nature Reviews Immunology, vol. 6, no. 6, pp. 476–483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  352. J. Valencia, C. Hernández-López, V. G. Martínez et al., “Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features,” Journal of Immunology, vol. 187, no. 8, pp. 4129–4139, 2011. View at Publisher · View at Google Scholar
  353. E. E. Hamilton-Williams, A. Lang, D. Benke, G. M. Davey, K.-H. Wiesmüller, and C. Kurts, “Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens,” Journal of Immunology, vol. 174, no. 3, pp. 1159–1163, 2005. View at Google Scholar
  354. C. G. King, T. Kobayashi, P. J. Cejas et al., “TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis,” Nature Medicine, vol. 12, no. 9, pp. 1088–1092, 2006. View at Publisher · View at Google Scholar · View at Scopus
  355. S. N. Mueller, M. Matloubian, D. M. Clemens et al., “Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 39, pp. 15430–15435, 2007. View at Publisher · View at Google Scholar · View at Scopus
  356. M. E. Mendes, G. L. Baggio-Zappia, M. K. C. Brunialti, M. D. L. Fernandes, M. M. Rapozo, and R. Salomao, “Differential expression of toll-like receptor signaling cascades in LPS-tolerant human peripheral blood mononuclear cells,” Immunobiology, vol. 216, no. 3, pp. 285–295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  357. S. M. Mangsbo, L. C. Sandin, K. Anger, A. J. Korman, A. Loskog, and T. H. Tötterman, “Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy,” Journal of Immunotherapy, vol. 33, no. 3, pp. 225–235, 2010. View at Publisher · View at Google Scholar
  358. J. M. Wells, O. Rossia, M. Meijerink, and P. Van Baarlen, “Epithelial crosstalk at the microbiota-mucosal interface,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. SUPPL. 1, pp. 4607–4614, 2011. View at Publisher · View at Google Scholar
  359. M. T. Abreu, “Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function,” Nature Reviews Immunology, vol. 10, no. 2, pp. 131–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  360. J. Lee, J. H. Mo, K. Katakura et al., “Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells,” Nature Cell Biology, vol. 8, no. 12, pp. 1327–1336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  361. B. Slütter and W. Jiskoot, “Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination,” Journal of Controlled Release, vol. 148, no. 1, pp. 117–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  362. J. L. Round, S. M. Lee, J. Li et al., “The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota,” Science, vol. 332, no. 6032, pp. 974–977, 2011. View at Publisher · View at Google Scholar
  363. J. M. Otte, E. Cario, and D. K. Podolsky, “Mechanisms of Cross Hyporesponsiveness to Toll-Like Receptor Bacterial Ligands in Intestinal Epithelial Cells,” Gastroenterology, vol. 126, no. 4, pp. 1054–1070, 2004. View at Publisher · View at Google Scholar · View at Scopus
  364. V. Cerovic, C. D. Jenkins, A. G. C. Barnes, S. W. F. Milling, G. G. MacPherson, and L. S. Klavinskis, “Hyporesponsiveness of intestinal dendritic cells to TLR stimulation is limited to TLR4,” Journal of Immunology, vol. 182, no. 4, pp. 2405–2415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  365. R. Zhou, H. Wei, R. Sun, J. Zhang, and Z. Tian, “NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 18, pp. 7512–7515, 2007. View at Publisher · View at Google Scholar · View at Scopus
  366. T. Karrasch, J. S. Kim, M. Muhlbauer, S. T. Magness, and C. Jobin, “Gnotobiotic IL-10-/-;NF-κBEGFP mice reveal the critical role of TLR/NF-κB signaling in commensal bacteria-induced colitis,” Journal of Immunology, vol. 178, no. 10, pp. 6522–6532, 2007. View at Google Scholar · View at Scopus
  367. M. Lotz, D. Gütle, S. Walther, S. Ménard, C. Bogdan, and M. W. Hornef, “Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells,” Journal of Experimental Medicine, vol. 203, no. 4, pp. 973–984, 2006. View at Publisher · View at Google Scholar
  368. C. Chassin, M. Kocur, J. Pott et al., “MiR-146a mediates protective innate immune tolerance in the neonate intestine,” Cell Host and Microbe, vol. 8, no. 4, pp. 358–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  369. J. Wang, H. R. Ford, and A. V. Grishin, “NF-κB-mediated expression of MAPK phosphatase-1 is an early step in desensitization to TLR ligands in enterocytes,” Mucosal Immunology, vol. 3, no. 5, pp. 523–534, 2010. View at Publisher · View at Google Scholar · View at Scopus
  370. J. M. Wells, L. M. P. Loonen, and J. M. Karczewski, “The role of innate signaling in the homeostasis of tolerance and immunity in the intestine,” International Journal of Medical Microbiology, vol. 300, no. 1, pp. 41–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  371. S. L. Lebeis, B. Bommarius, C. A. Parkos, M. A. Sherman, and D. Kalman, “TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium,” Journal of Immunology, vol. 179, no. 1, pp. 566–577, 2007. View at Google Scholar · View at Scopus
  372. K. Brandl, G. Plitas, B. Schnabl, R. P. DeMatteo, and E. G. Pamer, “MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1891–1900, 2007. View at Publisher · View at Google Scholar
  373. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov, “Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis,” Cell, vol. 118, no. 2, pp. 229–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  374. S. Milling, U. Yrlid, V. Cerovic, and G. MacPherson, “Subsets of migrating intestinal dendritic cells,” Immunological Reviews, vol. 234, no. 1, pp. 259–267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  375. B. M. Matta, A. Castellaneta, and A. W. Thomson, “Tolerogenic plasmacytoid DC,” European Journal of Immunology, vol. 40, no. 10, pp. 2667–2676, 2010. View at Publisher · View at Google Scholar · View at Scopus
  376. A. Goubier, B. Dubois, H. Gheit et al., “Plasmacytoid dendritic cells mediate oral tolerance,” Immunity, vol. 29, no. 3, pp. 464–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  377. U. Yrlid, S. W.F. Milling, J. L. Miller, S. Cartland, C. D. Jenkins, and G. G. MacPherson, “Regulation of intestinal dendritic cell migration and activation by plasmacytoid dendritic cells, TNF-α and type 1 IFNs after feeding a TLR7/8 ligand,” Journal of Immunology, vol. 176, no. 9, pp. 5205–5212, 2006. View at Google Scholar
  378. M. Miettinen, V. Veckman, S. Latvala, T. Sareneva, S. Matikainen, and I. Julkunen, “Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll-like receptor (TLR) gene expression in human primary macrophages,” Journal of Leukocyte Biology, vol. 84, no. 4, pp. 1092–1100, 2008. View at Publisher · View at Google Scholar
  379. C. Gómez-Llorente, S. Muñoz, and A. Gil, “Role of Toll-like receptors in the development of immunotolerance mediated by probiotics,” Proceedings of the Nutrition Society, vol. 69, no. 3, pp. 381–389, 2010. View at Publisher · View at Google Scholar
  380. J. L. Coombes and F. Powrie, “Dendritic cells in intestinal immune regulation,” Nature Reviews Immunology, vol. 8, no. 6, pp. 435–446, 2008. View at Publisher · View at Google Scholar · View at Scopus
  381. T. Feng, A. T. Cao, C. T. Weaver, C. O. Elson, and Y. Cong, “Interleukin-12 converts Foxp3+ regulatory T cells to interferonγ-producing Foxp3+ T cells that inhibit colitis,” Gastroenterology, vol. 140, no. 7, pp. 2031–2043, 2011. View at Publisher · View at Google Scholar
  382. J. L. Harden, T. Gu, M. O. Kilinc, R. B. Rowswell-Turner, L. P. Virtuoso, and N. K. Egilmez, “Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12 - driven antitumor T cell immunity,” Journal of Immunology, vol. 187, no. 1, pp. 126–132, 2011. View at Publisher · View at Google Scholar
  383. A. Snchezfueyo and T. B. Strom, “Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs,” Gastroenterology, vol. 140, no. 1, pp. 51–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  384. G. Orlando, P. Hematti, R. J. Stratta et al., “Clinical operational tolerance after renal transplantation: current status and future challenges,” Annals of Surgery, vol. 252, no. 6, pp. 915–928, 2010. View at Publisher · View at Google Scholar · View at Scopus
  385. V. Sordi and L. Piemonti, “Therapeutic plasticity of stem cells and allograft tolerance,” Cytotherapy, vol. 13, no. 6, pp. 647–660, 2011. View at Publisher · View at Google Scholar